Sulfonylurea Screen, Urine
Use
The Sulfonylurea Screen is utilized to detect the presence of sulfonylurea drugs in urine. This test is significant for identifying the use or misuse of these medications, which are typically used to treat type 2 diabetes. Detection of these drugs can assist in diagnosing potential drug interactions, overdose, or confirming adherence to prescribed medication regimens.
Special Instructions
Not provided.
Limitations
The test has a reference range that is not established, which means results should be interpreted cautiously. Variability in individual metabolism and drug interactions can affect results. Potential interference by other medications or substances should be considered.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
LOINC Codes
- 27164-3 - acetoHEXAMIDE Ur-mCnc
- 12396-8 - chlorproPAMIDE Ur-mCnc
- 27166-8 - TOLAZamide Ur-mCnc
- 27170-0 - TOLBUTamide Ur-mCnc
- 73691-8 - Glimepiride Ur-mCnc
- 27025-6 - glipiZIDE Ur-mCnc
- 27175-9 - glyBURIDE Ur-mCnc
- 73690-0 - Nateglinide Ur-mCnc
- 73689-2 - Repaglinide Ur-mCnc
Result Turnaround Time
5-11 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
5 mL
Minimum Volume
1.2 mL
Container
Plastic urine container
Collection Instructions
Collect 5 mL random urine without preservative and ship refrigerated.
Storage Instructions
Ship refrigerated.
Causes for Rejection
NA
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 14 days |
| Frozen | 180 days |